Chiron Off The Hook For Securities Violations

Law360, New York (February 7, 2006, 12:00 AM EST) -- The U.S. Securities and Exchange Commission has closed its investigation into whether Chiron Corp. violated any federal securities laws, the biotech company said Tuesday.

In October 2004, the SEC began informally investigating Chiron in connection with the unexpected suspension of Chiron's license to manufacture an influenza virus vaccine, Fluviron, by the United Kingdom’s Medicines and Healthcare Products Regulatory Agency. The suspension was due to concerns of contamination.

U.S. securities regulators wanted to know what the company could and should have told investors about its vaccine manufacturing...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.